Indonesia
Medizinprodukt-Marktintelligenz für Indonesia. Regulatorische Änderungen, Wettbewerber und Beschaffungstrends.
Neueste Signale
Asia faces a plastic shortage due to the Iran war, impacting medical device supply chains and increasing prices.
Thai police arrested a 33-year-old Indonesian for $10 million cyber fraud after an FBI tip-off.
Chinese investors are transforming Borneo's jungle into Indonesia's new capital, Nusantara, set for 2028.
WHO prequalified a new measles vaccine for children's prevention, enhancing supply and access.
Vietnam and the Philippines trust Japan significantly, while Indonesia remains cautious due to its non-alignment policy.
The US-Indonesia defense pact enhances maritime security, impacting China's strategic position in the region.
Southeast Asia's work-from-home policies may not significantly reduce energy costs as anticipated by governments.
Singapore has surpassed Indonesia in ASEAN leadership due to President Prabowo's external focus.
Japan's 7.7 magnitude quake raises Bali's risk of an 8+ magnitude earthquake to 1% from 0.1%.
ASICS is launching badminton shoes in Malaysia and Singapore, and soccer cleats in Indonesia.
Indonesia provides 24/7 health services for Hajj pilgrims to ensure their well-being during the pilgrimage.
Indonesia's new nutrition labels aim to address obesity but are seen as just a first step by experts.
A million lives were saved from malaria last year, but drug resistance poses a significant threat to progress.
WHO reports rising antibiotic resistance in gonorrhoea, urging enhanced surveillance and treatment access.
SS Innovations' robot gains telesurgery approvals in Indonesia and the Philippines; XCath performs remote thrombectomy.
WHO's first Global Forum unites over 800 Collaborating Centres to enhance scientific collaboration for public health.
AI is revolutionizing TB screening with handheld X-ray devices in over 22 countries.
Philips recalls ALLURA Xper FD20 OR Table due to intermittent X-ray imaging issues with the foot switch.
Medtronic MiniMed's Paradigm Insulin Pumps are recalled due to risks of insulin over- and under-delivery affecting patient safety.
Philips recalled Azurion 5 M12 due to intermittent X-ray imaging issues with the wired foot switch.